Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Share-based Compensation (2020 - 2026)

Updated

Barinthus Biotherapeutics' Share-based Compensation was $433,000 in Q2 2026, compared with -$281,000 a year earlier and down 22.1% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Share-based Compensation (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Barinthus Biotherapeutics' Share-based Compensation was $1.27 million through Jun 30, 2026, down 39.1% year-over-year; for FY2025, it was $468,000, down 90.1% from FY2024.

  • Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -33.6% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $4.71 million in FY2024 (-6.8%), $5.06 million in FY2023 (-48.8%), $9.88 million in FY2022 (-40.1%) and $16.49 million in FY2021 (+354.8%).
  • Quarterly Share-based Compensation has moved between -$415,000 (Q3 2025) and $3.98 million (Q1 2022) over five years.
  • Compared with a year earlier, Share-based Compensation was higher in 1 of the last four quarters, with an average decline of 16.0%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 399.9%); the worst was Q3 2023 (a decline of 94.8%).
  • Per Business Quant data, BRNS's Share-based Compensation in the three quarters before Q2 2026 was $556,000 (Q1 2026), $696,000 (Q4 2025) and -$415,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - 433,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 433,000.00
Mar 31, 2026 556,000.00
Dec 31, 2025 696,000.00
Sep 30, 2025 -415,000.00
Jun 30, 2025 -281,000.00
Mar 31, 2025 468,000.00
Dec 31, 2024 755,000.00
Sep 30, 2024 1.14 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.62 Mn
Dec 31, 2023 786,000.00
Sep 30, 2023 57,000.00
Jun 30, 2023 1.99 Mn
Mar 31, 2023 2.22 Mn
Dec 31, 2022 2.04 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 2.75 Mn
Mar 31, 2022 3.98 Mn
Dec 31, 2021 3.58 Mn
Sep 30, 2021 3.37 Mn
API Access

Barinthus Biotherapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BRNS&period=max&api_key=YOUR_API_KEY